Amendment to Registration of Securities of a Foreign Private Issuer — Form 20-F Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 20FR12B/A Amendment to Registration of Securities of a HTML 1.67M
Foreign Private Issuer
2: EX-1.8 Underwriting Agreement -- exhibit1-8 HTML 16K
3: EX-15.1 Letter re: Unaudited Interim Financial Information HTML 5K -- exhibit15-1
4: EX-15.2 Letter re: Unaudited Interim Financial Information HTML 5K
-- exhibit15-2
EX-15.1 — Letter re: Unaudited Interim Financial Information — exhibit15-1
Trillium Therapeutics Inc.: Exhibit 15.1 - Filed by newsfilecorp.com
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption
“Statement by Experts” and to the use of our reports dated March 27, 2014 and
April 29, 2013 with respect to the financial statements of Trillium Therapeutics
Inc. (formerly Stem Cell Therapeutics Corp.) in the Registration Statement on
Form 20-F (Amendment No. 2) for the registration of common shares of Trillium
Therapeutics Inc.